|
|
|
|
Naturally positioned OTCs, mergers and acquisitions, and new, innovative switches are all impacting the dynamics of the U.S. nonprescription drugs industry. Small, niche companies, such as Matrixx Initiatives, Hisamitsu Pharmaceutical, Quincy Biosciences, and Zarbee’s Naturals, post robust growth between 10% and 20%.
The addition of Rhinocort Allergy Spray by Johnson & Johnson to the OTC market, coupled with the existing Flonase Allergy Relief by GlaxoSmithKline, boosts the nasal allergy sprays category by double digits. Meanwhile, other categories, such as topical analgesics, internal analgesics, herbal products, and contraceptive products, are all experiencing stronger than average sales growth.
Key industry trends and drivers
The impact of recent Rx-to-OTC switches
New product introductions
Changes in distribution
Rapidly growing brands
Probiotics and digestive health
Laura MahechaIndustry Manager of Kline's Healthcare and I&I Practices, responsible for numerous market studies in the area of OTC pharmaceuticals, consumer products, nutritional supplements, and industrial and institutional cleaners.
Takes a deep dive into the OTC industry to reveal the latest trends, challenges, and developments.
Reveals sales data, growth, share, and forecasts for hundreds of brands across 30 categories in the OTC space.
Features sales by product category and major brands, recent developments, new products, corporate overview, and future outlook.
Date: Tuesday, June 27, 2017
Time: 10:30 AM EDT / 2:30 PM GMT
We combine a distinctive package of consulting and research capabilities, global reach, and industry understanding that cannot be matched by our competitors. Our focus is on providing knowledge and solutions throughout the entire value chains of the industries we serve.
